|
Quality of life (QoL) and overall survival (OS) in patients (pts) with advanced clear-cell renal cell carcinoma (aRCC) treated with nivolumab (NIVI) vs. everolimus (EVE) in the phase III CheckMate 025 study. |
|
|
Stock and Other Ownership Interests - FACIT.org |
Consulting or Advisory Role - Abbvie; Bayer; GlaxoSmithKline; Pfizer |
Research Funding - Bayer (Inst); Genentech (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - Bayer; GlaxoSmithKline |
|
|
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer |
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer |
Speakers' Bureau - Novartis |
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Novartis; Pfizer |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche |
Speakers' Bureau - Bristol-Myers Squibb; Novartis |
Research Funding - AstraZeneca (Inst); Novartis (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD |
|
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
|
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb |
Research Funding - Bristol-Myers Squibb (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Berry Consultants (Inst) |
Research Funding - Berry Consultants (Inst) |
Patents, Royalties, Other Intellectual Property - Berry Consultants (Inst) |
Other Relationship - Berry Consultants |
|
|
Consulting or Advisory Role - Berry Consultants (Inst) |
|
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
|
|
Consulting or Advisory Role - Eisai; Novartis; Pfizer |
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |